Publication Registration: |
Wednesday, September 5, 2018 |
Description:
|
(1) - Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking cessation and discouraging smoking habits, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine, Parkinson's Disease OFF hypomobility episodes, binge eating disorders, pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, pharmaceutical preparations for the treatment of Parkinson's Disease and therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease
(2) - Pharmaceutical preparations for treating central nervous system diseases or disorders
(3) - Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking cessation and discouraging smoking habits, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine, Parkinson's Disease OFF hypomobility episodes, binge eating disorders, pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, pharmaceutical preparations for the treatment of Parkinson's Disease and therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease
(4) - Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking cessation and discouraging smoking habits, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine, Parkinson's Disease OFF hypomobility episodes, binge eating disorders, pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, pharmaceutical preparations for the treatment of Parkinson's Disease and therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease
|